Hamps Bio IPO , a SME IPO worth ₹5.91 Cr, was launched from December 13, 2024, to December 17, 2024, and got listed on BSE SME on December 20, 2024. The public issue of Hamps Bio IPO (544312) was offered at ₹51.00 per share and was listed at ₹96.90, delivering a listing gain of 90.00%. With a minimum lot size of 2000 shares, the IPO providing a return of ₹91800 per lot on listing. Hamps Bio IPO GMP Subscription Status Listing Date: Hamps Bio IPO surges with strong demand; subscription ends Dec 17. A positive GMP premium signals that the IPO is likely to be at profit while a negative GMP indicates that the IPO is likely to be at a discount. It should be noted that IPO GMP is subject to extreme volatility, so an investment decision based solely on Hamps Bio SME IPO GMP will prove risky. Check out Hamps Bio IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Hamps Bio IPO GMP started. Stay tuned for the latest IPO GMP numbers of Hamps Bio IPO . Hamps Bio IPO GMP made a high of ₹55 of 21st December against a low of ₹21 that was on 12th December.
